Study aim: Evaluation of the efficacy of Ipecac homeopathy remedy in controlling covid-19 disease symptoms and accelerating the recovery process Design: A randomized, controlled, double-blind, placebo-controlled clinical trial Settings and conduct: Patients with covid19 admitted to rasoul-e-Akram and Firoozgar Hospitals are included in the study. Both patient and therapist are blinded Participants/Inclusion and exclusion criteria: Inclusion criteria: Patients admitted with suspicious or definite diagnosis of Covid-19(according to national guideline). Definition of Covid-19 Suspected Case: A. Patient with respiratory symptoms with radiologic manifestations of unilateral or bilateral multilobular infiltration on CT scan or chest x-ray B- Pneumoniae person who despite the appropriate treatments, has poor clinical response and in an unusual and unexpected way the patient's clinical condition becomes more acute and aggravated. Exclusion criteria: • Patients who are treated with corticosteroids or immunosuppressants for any reason. • Patients who cannot take oral medication due to decreased consciousness. Intervention groups: Ipecac homeopathy remedy is prescribed with dose of 15 drops every 2 hours for 6 hours and then 15 drops every 6 hours for 3 days. Main outcome variables: Fever; Cough; Shortness of breath; Chills; Myalgia; O2 Saturation; Number of days admitted; Number of lymphocytes; Serum CRP level; Ventilator requirement; Oxygen intake and rout of its use and finally side effect of urticaria, itching and eruption.